265 related articles for article (PubMed ID: 32546644)
1. Functional Categorization of
Bouwman P; van der Heijden I; van der Gulden H; de Bruijn R; Braspenning ME; Moghadasi S; Wessels LFA; ; Vreeswijk MPG; Jonkers J
Clin Cancer Res; 2020 Sep; 26(17):4559-4568. PubMed ID: 32546644
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Bouwman P; van der Gulden H; van der Heijden I; Drost R; Klijn CN; Prasetyanti P; Pieterse M; Wientjens E; Seibler J; Hogervorst FB; Jonkers J
Cancer Discov; 2013 Oct; 3(10):1142-55. PubMed ID: 23867111
[TBL] [Abstract][Full Text] [Related]
3.
Lourenço RA; Lança M; Monteiro Gil O; Cardoso J; Lourenço T; Pereira-Leal JB; Rodrigues AS; Rueff J; Nunes Silva S
Mol Med Rep; 2023 Jul; 28(1):. PubMed ID: 37232349
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.
Santos C; Peixoto A; Rocha P; Pinto P; Bizarro S; Pinheiro M; Pinto C; Henrique R; Teixeira MR
J Mol Diagn; 2014 May; 16(3):324-34. PubMed ID: 24607278
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 Circos: a visualisation resource for functional analysis of missense variants.
Jhuraney A; Velkova A; Johnson RC; Kessing B; Carvalho RS; Whiley P; Spurdle AB; Vreeswijk MP; Caputo SM; Millot GA; Vega A; Coquelle N; Galli A; Eccles D; Blok MJ; Pal T; van der Luijt RB; Santamariña Pena M; Neuhausen SL; Donenberg T; Machackova E; Thomas S; Vallée M; Couch FJ; Tavtigian SV; Glover JN; Carvalho MA; Brody LC; Sharan SK; Monteiro AN;
J Med Genet; 2015 Apr; 52(4):224-30. PubMed ID: 25643705
[TBL] [Abstract][Full Text] [Related]
6. DNA repair function scores for 2172 variants in the BRCA1 amino-terminus.
Diabate M; Islam MM; Nagy G; Banerjee T; Dhar S; Smith N; Adamovich AI; Starita LM; Parvin JD
PLoS Genet; 2023 Aug; 19(8):e1010739. PubMed ID: 37578980
[TBL] [Abstract][Full Text] [Related]
7. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays.
Bassi N; Hovland HN; Rasheed K; Jarhelle E; Pedersen N; Mchaina EK; Bakkan SME; Iversen N; Høberg-Vetti H; Haukanes BI; Knappskog PM; Aukrust I; Ognedal E; Van Ghelue M
BMC Cancer; 2023 Apr; 23(1):368. PubMed ID: 37085799
[TBL] [Abstract][Full Text] [Related]
8. Integration of functional assay data results provides strong evidence for classification of hundreds of BRCA1 variants of uncertain significance.
Lyra PCM; Nepomuceno TC; de Souza MLM; Machado GF; Veloso MF; Henriques TB; Dos Santos DZ; Ribeiro IG; Ribeiro RS; Rangel LBA; Richardson M; Iversen ES; Goldgar D; Couch FJ; Carvalho MA; Monteiro ANA
Genet Med; 2021 Feb; 23(2):306-315. PubMed ID: 33087888
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of BRCA1 and BRCA2 variants of uncertain significance in patients with breast cancer: a multifactorial probability-based model versus ACMG standards and guidelines for interpreting sequence variants.
Park KS; Cho EY; Nam SJ; Ki CS; Kim JW
Genet Med; 2016 Dec; 18(12):1250-1257. PubMed ID: 27124784
[TBL] [Abstract][Full Text] [Related]
10. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
[TBL] [Abstract][Full Text] [Related]
11. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
Toland AE; Andreassen PR
J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
[TBL] [Abstract][Full Text] [Related]
12. Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance.
Langerud J; Jarhelle E; Van Ghelue M; Ariansen SL; Iversen N
Hum Genomics; 2018 Nov; 12(1):51. PubMed ID: 30458859
[TBL] [Abstract][Full Text] [Related]
13. Reclassification of
Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
[TBL] [Abstract][Full Text] [Related]
14. BRCA1/2 sequence variants of uncertain significance: a primer for providers to assist in discussions and in medical management.
Lindor NM; Goldgar DE; Tavtigian SV; Plon SE; Couch FJ
Oncologist; 2013; 18(5):518-24. PubMed ID: 23615697
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of 84 PALB2 variants of uncertain significance.
Wiltshire T; Ducy M; Foo TK; Hu C; Lee KY; Belur Nagaraj A; Rodrigue A; Gomes TT; Simard J; Monteiro ANA; Xia B; Carvalho MA; Masson JY; Couch FJ
Genet Med; 2020 Mar; 22(3):622-632. PubMed ID: 31636395
[TBL] [Abstract][Full Text] [Related]
16. Validation and Data-Integration of Yeast-Based Assays for Functional Classification of BRCA1 Missense Variants.
Bellè F; Mercatanti A; Lodovichi S; Congregati C; Guglielmi C; Tancredi M; Caligo MA; Cervelli T; Galli A
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409408
[TBL] [Abstract][Full Text] [Related]
17. A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS).
Lindor NM; Guidugli L; Wang X; Vallée MP; Monteiro AN; Tavtigian S; Goldgar DE; Couch FJ
Hum Mutat; 2012 Jan; 33(1):8-21. PubMed ID: 21990134
[TBL] [Abstract][Full Text] [Related]
18. Variants of uncertain significance in BRCA1 and BRCA2 assessment of in silico analysis and a proposal for communication in genetic counselling.
Moghadasi S; Hofland N; Wouts JN; Hogervorst FB; Wijnen JT; Vreeswijk MP; van Asperen CJ
J Med Genet; 2013 Feb; 50(2):74-9. PubMed ID: 23231788
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
[TBL] [Abstract][Full Text] [Related]
20. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
